EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $452,000 | +33.3% | 18,973 | +10.2% | 0.17% | -59.5% |
Q4 2018 | $339,000 | +5.0% | 17,215 | -5.6% | 0.41% | -24.5% |
Q3 2018 | $323,000 | +45.5% | 18,237 | +76.8% | 0.55% | +53.8% |
Q2 2018 | $222,000 | -54.5% | 10,316 | -53.2% | 0.36% | +83.0% |
Q1 2018 | $488,000 | -19.9% | 22,020 | +10.0% | 0.19% | -34.7% |
Q4 2017 | $609,000 | +14.0% | 20,020 | -9.1% | 0.30% | -45.8% |
Q3 2017 | $534,000 | – | 22,020 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |